Senboll Biotechnology Co, Ltd. Website-A Pioneer in the Detection of Organic Lesions in the Digestive Tract
  • A Pioneer in the Detection of Organic Lesions in the Digestive Tract.
    A Pioneer in the Detection of Organic Lesions in the Digestive Tract.

  • Adhering to the Product Design of Precision, Simplicity, Speed, and Economy
    Adhering to the Product Design of Precision, Simplicity, Speed, and Economy

About Us

A Pioneer in the Detection of Organic Lesions in the Digestive Tract.
Shenzhen Senboll Biotechnology Co, Ltd., founded in 2017, is led by a founder with over 20 years of deep expertise in life sciences, who previously served as a discipline leader at renowned research institutions in Europe and the United States. The company is dedicated to the independent R&D of ...
View Details +

Our History

  • 2025
    The independently developed REG1A serum reagent has officially obtained the medical apparatus registration certificate issued by the Guangdong Provincial Drug Administration (Guangdong Machinery Note 20252400165).
  • 2022
    2022 Shenzhen International BioPharmaceutical Industry Innovation and Development ConferenceShenzhen Sunbowell Life Technologies' reagent kit for the detection of gastrointestinal organic lesions obtained EU CE certification.
  • 2019
    Senbollbio Wins "Top 50 Biotech Innovation Enterprises - Rising Star" Award at the 2nd Greater Bay Area Biotech Innovation Awards.
  • 2017
    In 2017, Professor Guo founded Senbollbio Technologies after winning an award at the inaugural Shenzhen Innovation Competition International Contest.